{"result": {"id": "748f7798-a704-4e1b-adc5-62bbc857cc78", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Fuwai Hospital and Cardiovascular Guidelines Community\",\n    \"summary\": \"The community centers around Fuwai Hospital, Chinese Academy of Medical Sciences, a leading institution in cardiovascular disease treatment and research in China. Key entities include prominent medical professionals like Wang Zengwu, Li Jianjun, and Gao Runlin, who are involved in the revision and publication of national guidelines for cardiovascular and lipid management. The community's structure is characterized by strong professional affiliations and collaborative efforts in guideline development, with significant contributions to clinical practices and research in cardiovascular health.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The high impact severity rating reflects the community's central role in shaping cardiovascular health policies and practices in China through authoritative guideline development and research.\",\n    \"findings\": [\n        {\n            \"summary\": \"Fuwai Hospital's pivotal role in cardiovascular health\",\n            \"explanation\": \"Fuwai Hospital, Chinese Academy of Medical Sciences, stands as the cornerstone of this community, renowned for its leadership in cardiovascular disease treatment and research. Its affiliation with key medical professionals and involvement in national guideline development underscores its influence in the field. The hospital's contributions to clinical practices and research have a profound impact on cardiovascular health management in China. [Data: Entities (897), Relationships (1102, 1397, 1402, 1403, 1404,+more)]\"\n        },\n        {\n            \"summary\": \"Key figures in guideline development\",\n            \"explanation\": \"Medical professionals such as Wang Zengwu, Li Jianjun, and Gao Runlin play critical roles in the revision and publication of national cardiovascular and lipid management guidelines. Their expertise and leadership in guideline development ensure the dissemination of evidence-based practices across China's healthcare system. [Data: Entities (1462, 1463, 2028), Relationships (1102, 1333, 1041,+more)]\"\n        },\n        {\n            \"summary\": \"Collaborative efforts in guideline revision\",\n            \"explanation\": \"The China Joint Expert Committee for Revision of Blood Lipid Management Guidelines exemplifies the community's collaborative approach to improving lipid management practices. By bringing together experts from various institutions, the committee ensures that guidelines are comprehensive and reflect the latest clinical evidence. [Data: Entities (1428), Relationships (1016, 1015,+more)]\"\n        },\n        {\n            \"summary\": \"Dissemination of guidelines through reputable journals\",\n            \"explanation\": \"The Chinese Journal of Cardiology serves as a key platform for publishing cardiovascular guidelines, facilitating their widespread adoption among medical professionals. The journal's role in disseminating authoritative guidelines enhances the community's impact on clinical practices. [Data: Entities (1429), Relationships (1016, 2382)]\"\n        },\n        {\n            \"summary\": \"Integration of research and clinical practice\",\n            \"explanation\": \"The community's efforts in guideline development are closely tied to research initiatives, ensuring that clinical practices are grounded in the latest scientific evidence. This integration underscores the community's commitment to advancing cardiovascular health through evidence-based medicine. [Data: Entities (1428, 1429), Relationships (1016, 1041,+more)]\"\n        }\n    ]\n}", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1753518516, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 660, "prompt_tokens": 5456, "total_tokens": 6116, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1920}, "prompt_cache_hit_tokens": 1920, "prompt_cache_miss_tokens": 3536}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            },\n            {\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }\n        ]\n    }\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nLimit the total report length to 2000 words.\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        },\n        {\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        },\n        {\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        },\n        {\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }\n    ]\n}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\r\n897,中国医学科学院阜外医院,\"中国医学科学院阜外医院（Fuwai Hospital, Chinese Academy of Medical Sciences）是中国领先的心血管疾病专科医院，隶属于中国医学科学院（Chinese Academy of Medical Sciences）。作为国内心血管领域的权威机构，该医院在临床诊疗、科研创新和指南制定方面具有重要影响力。部分心血管疾病指南编写专家组的成员来自该医院，凸显了其在行业内的专业地位和学术贡献。  \n\n该医院以“中国领先的心血管医院”著称，长期致力于心血管疾病的预防、治疗和研究工作，并在国内外享有较高声誉。其名称在不同语境下可能以“阜外医院”或“中国医学科学院阜外医院”出现，但均指向同一机构。作为医疗机构，它不仅是高水平医疗服务的提供者，同时也是心血管领域专家的重要执业和科研平台。  \n\n综上，中国医学科学院阜外医院是中国心血管医学领域的核心机构之一，集临床、科研和教学于一体，并在国家级指南制定中发挥关键作用。\",8\r\n1462,王增武,\"**王增武** is a prominent medical professional affiliated with **Fuwai Hospital, Chinese Academy of Medical Sciences**, where he serves as a **chief physician and professor**. He has played a significant role in the development and revision of medical guidelines in China, particularly in the fields of **hypertension and dyslipidemia management**.  \n\n王增武 contributed to the **expert consensus on comprehensive management of blood pressure and lipids in Chinese hypertensive patients**, highlighting his expertise in cardiovascular health. Additionally, he is recognized as a **key figure in the revision of medical guidelines**, underscoring his influence in shaping clinical practices.  \n\nAs a **corresponding author of the guideline**, 王增武 has been instrumental in advancing standardized care protocols. Notably, he is one of the authors of the **Chinese dyslipidemia management guidelines (2024 edition)**, further solidifying his leadership in cardiovascular disease prevention and treatment.  \n\nHis work reflects a commitment to improving patient outcomes through evidence-based medicine, with a focus on integrating blood pressure and lipid management strategies. Through his affiliations, research, and guideline contributions, 王增武 remains a central figure in China's efforts to address hypertension and dyslipidemia.\",4\r\n1429,中华心血管病杂志,\"The *中华心血管病杂志* (Chinese Journal of Cardiology) is a Chinese medical journal dedicated to publishing research, clinical studies, and guidelines related to cardiovascular diseases. It serves as a key resource for medical professionals and researchers in the field of cardiology, covering topics such as disease mechanisms, treatment strategies, and preventive care. Notably, the journal has contributed to the dissemination of important clinical guidelines, including the publication of lipid-lowering treatment target values as early as 1977.  \n\nWhile the journal is referred to by slightly varying names—such as *Chinese Journal of Cardiology*—it remains consistent in its focus on advancing cardiovascular medicine in China. The descriptions provided do not present contradictions but rather complementary details about its scope and historical contributions. The journal continues to play a significant role in shaping cardiovascular research and clinical practice in the Chinese medical community.\",4\r\n1428,中国血脂管理指南修订联合专家委员会,\"The **中国血脂管理指南修订联合专家委员会** (China Joint Expert Committee for Revision of Blood Lipid Management Guidelines) is a collaborative body of experts tasked with updating and refining China's national guidelines on blood lipid (dyslipidemia) management. The committee is responsible for revising multiple iterations of these guidelines, including the *China Lipid Management Guidelines (2023)* and the *Chinese Guideline for Lipid Management (Primary Care Version 2024)*.  \n\nThis joint expert committee plays a pivotal role in standardizing and improving lipid management practices across China, ensuring that recommendations align with the latest clinical evidence and address both specialized and primary care needs. While the descriptions vary slightly in naming conventions—referring to \"\"blood lipid,\"\" \"\"lipid,\"\" or \"\"dyslipidemia\"\" management—they consistently emphasize the committee's central function: the authoritative revision of China's guidelines to enhance patient care and treatment protocols.  \n\nThe committee's work spans broader clinical guidelines (2023) as well as targeted primary care editions (2024), reflecting a comprehensive approach to lipid management across healthcare tiers. No substantive contradictions exist among the descriptions; minor discrepancies in phrasing (e.g., \"\"blood lipid\"\" vs. \"\"dyslipidemia\"\") likely stem from contextual or translational differences. The unified summary underscores the committee's role as the definitive body for guideline revisions in this field.  \n\n(Word count: 198)\",6\r\n1463,李建军,\"**Li Jianjun** is a prominent medical professional and researcher specializing in cardiovascular health, particularly in the management of hypertension and dyslipidemia in Chinese patients. He holds the position of chief physician and professor at Fuwai Hospital, Chinese Academy of Medical Sciences, and has played a significant role in the development of clinical guidelines in China.  \n\nLi Jianjun contributed to the *Expert Consensus on Comprehensive Management of Blood Pressure and Lipids in Chinese Hypertensive Patients* and served as a corresponding author for the guideline. Additionally, he was a member of the expert group responsible for revising these guidelines. His expertise extends to dyslipidemia management, as evidenced by his authorship of the *Chinese Dyslipidemia Management Guidelines (2024 Edition)*.  \n\nThrough his work, Li Jianjun has established himself as a key figure in shaping evidence-based practices for cardiovascular disease prevention and treatment in China. His affiliations with Fuwai Hospital and his involvement in national guideline development highlight his leadership in the field.\",4\r\n2028,高润霖,\"**高润霖** is an esteemed academician of the Chinese Academy of Engineering and a prominent researcher in the medical field. He holds a key role as the corresponding author of a significant guideline and serves as the coordinator of the guideline revision expert group. His professional affiliation is with **Fuwai Hospital, Chinese Academy of Medical Sciences**, where he contributes to advancing medical research and practice. Combining these roles, 高润霖 is recognized for his leadership in guideline development and his expertise in cardiovascular medicine, leveraging his position at Fuwai Hospital to influence clinical standards and research directions. His work reflects a commitment to bridging academic research and practical healthcare improvements.\",2\r\n2084,郭远林,\"A medical expert affiliated with the Chinese Academy of Medical Sciences Fuwai Hospital\"\"\",1\r\n2093,窦克非,\"A medical professional at the Chinese Academy of Medical Sciences Fuwai Hospital\"\"\",1\r\n2095,马丽媛,\"A member of the guideline revision secretariat, associated with the Chinese Academy of Medical Sciences Fuwai Hospital\"\"\",1\r\n2096,高莹,\"A member of the guideline revision secretariat, affiliated with the Chinese Academy of Medical Sciences Fuwai Hospital\"\"\",1\r\n1427,“三高”共管规范化诊疗中国专家共识专家组,\"Expert group that developed the Chinese consensus on standardized management of \"\"three highs\"\" (hypertension, hyperlipidemia, and hyperglycemia)>\",2\r\n3478,李凌江,\"李凌江（Li Lingjiang）是中南大学湘雅二医院（Second Xiangya Hospital of Central South University）的神经精神专家组成员，主要从事精神健康领域的研究工作，并担任相关学术论文的通讯作者。此外，他还参与医学指南的评审工作，展现了其在临床实践与学术研究中的专业影响力。  \n\n作为中南大学湘雅二医院的资深专家，李凌江在神经精神医学领域具有深厚的学术背景和临床经验。他的研究聚焦于精神健康，致力于推动该领域的科学进展，并通过学术合作与论文发表促进知识传播。同时，他在医学指南的评审中发挥重要作用，确保临床实践的科学性与规范性，进一步巩固了其在专业领域的权威地位。  \n\n综上，李凌江是一位集科研、临床与学术评审于一身的神经精神科专家，其工作涵盖理论研究与实践应用，为精神医学的发展作出了贡献。\",4\r\n2080,中南大学湘雅二医院,\"**中南大学湘雅二医院** (The Second Xiangya Hospital of Central South University) is a prominent medical institution affiliated with **Central South University**. It provides comprehensive healthcare services and is recognized for its contributions to medical research, particularly in the field of **mental health**. The hospital serves as the workplace for notable professionals such as **李凌江 (Li Lingjiang)** and **胡治平 (Hu Zhiping)**, further highlighting its role as a key healthcare and research center.  \n\nAs a major teaching hospital, it combines clinical care with academic excellence, offering specialized services and advancing medical knowledge through research initiatives. Its affiliation with **Central South University** underscores its commitment to high standards in education, patient care, and innovation. The hospital is also referred to as **\"\"The Second Xiangya Hospital of Central South University,\"\"** emphasizing its position within the Xiangya medical network.  \n\nIn summary, **中南大学湘雅二医院** is a leading healthcare institution with a strong academic foundation, renowned for its comprehensive services, mental health research, and association with distinguished medical professionals.\",4\r\n926,张宇清,\"张宇清是中国医学科学院阜外医院的心血管专家，同时也是《心血管疾病基层诊疗指南》的执笔专家和主要作者。他在心血管疾病领域具有深厚的专业知识和丰富的临床经验，致力于基层医疗诊疗规范的制定与推广。作为该指南的执笔专家，张宇清在编写过程中发挥了核心作用，为基层医生提供了科学、实用的诊疗指导，体现了他在学术研究和临床实践中的权威地位。他的工作对提升中国基层心血管疾病的诊疗水平具有重要意义。  \n\n（注：以上摘要整合了两条描述信息，确认了张宇清的专家身份、所属机构、指南编写角色及贡献，未发现矛盾点，总字数控制在500字以内。）\",3\r\n1481,陈源源,\"A contributor to the expert consensus on comprehensive management of blood pressure and lipids in Chinese hypertensive patients\"\"\",2\r\n2027,赵水平,\"**Zhao Shuiping** is a chief physician and professor affiliated with Xiangya Second Hospital at Central South University. He holds a prominent role in the medical field as both a corresponding author of a clinical guideline and a member of the guideline revision expert group. His dual involvement highlights his expertise and leadership in developing and refining medical guidelines, contributing to evidence-based practice in his specialty. As a senior medical professional, Zhao Shuiping combines clinical practice with academic contributions, reinforcing his influence in healthcare standards and policy development.\",2\r\n3023,《中国高血压防治指南》修订委员会,Committee responsible for revising the Chinese hypertension prevention and treatment guidelines,2\r\n2087,彭道泉,\"A medical specialist affiliated with Xiangya Hospital of Central South University\"\"\",1\r\n3483,精神疾病诊疗技术国家地方联合工程实验室,National Local Joint Engineering Laboratory for Diagnosis and Treatment Technology of Mental Disorders is a laboratory focused on mental disorder diagnostics and treatment>,1\r\n3484,精神病学与精神卫生学湖南省重点实验室,Hunan Key Laboratory of Psychiatry and Mental Health is a provincial key laboratory focused on psychiatry and mental health>,1\r\n3733,胡治平,,1\r\n1206,中国医药科技出版社,\"**中国医药科技出版社 (China Medical Science and Technology Press)** is a Beijing-based publishing house specializing in medical literature and scientific research. Established in China, the press is known for its contributions to the field of medicine, including the publication of guidelines for clinical research of new Chinese medicines in 2002. As a reputable publisher, it focuses on disseminating authoritative medical knowledge, supporting advancements in healthcare, and promoting research in traditional and modern medicine. The press plays a significant role in bridging academic and clinical practices by producing high-quality publications for professionals and researchers in the medical field.\",3\r\n1207,郑筱萸,An author who wrote guidelines for clinical research of new Chinese medicines>,1\r\n1426,中国心血管健康与疾病报告编写组,\"The editorial team responsible for the \"\"China Cardiovascular Health and Disease Report 2022,\"\" a key reference for cardiovascular health data in China>\",1\r\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\r\n1102,中国医学科学院阜外医院,王增武,\"中国医学科学院阜外医院（Fuwai Hospital, Chinese Academy of Medical Sciences）是王增武的任职机构。王增武作为该医院的重要成员，在医学指南修订工作中发挥了关键作用。他的工作单位在描述中一致指向中国医学科学院阜外医院，凸显其在该机构的专业地位和贡献。  \n\n王增武与中国医学科学院阜外医院的关联在两条描述中均得到明确印证，且信息无矛盾。综合来看，他是该医院的核心专家之一，尤其在医学指南修订领域具有显著影响力。\",12\r\n1016,中华心血管病杂志,中国血脂管理指南修订联合专家委员会,The committee published the 2023 guidelines in the journal,10\r\n1041,李建军,中国血脂管理指南修订联合专家委员会,李建军 is a member of the Chinese dyslipidemia management guidelines revision joint expert committee,10\r\n1333,中国血脂管理指南修订联合专家委员会,王增武,王增武 is a corresponding author of the guideline published by the committee,10\r\n1397,高润霖,中国医学科学院阜外医院,\"高润霖 is affiliated with Fuwai Hospital, Chinese Academy of Medical Sciences\",10\r\n1402,中国医学科学院阜外医院,郭远林,郭远林 is affiliated with the Chinese Academy of Medical Sciences Fuwai Hospital,9\r\n1403,中国医学科学院阜外医院,窦克非,窦克非 is a medical professional at the Chinese Academy of Medical Sciences Fuwai Hospital,9\r\n1404,中国医学科学院阜外医院,马丽媛,\"马丽媛 is a member of the guideline revision secretariat, associated with the Chinese Academy of Medical Sciences Fuwai Hospital\",9\r\n1405,中国医学科学院阜外医院,高莹,\"高莹 is a member of the guideline revision secretariat, affiliated with the Chinese Academy of Medical Sciences Fuwai Hospital\",9\r\n1015,“三高”共管规范化诊疗中国专家共识专家组,中国血脂管理指南修订联合专家委员会,Both develop consensus and guidelines for managing lipid disorders and related conditions in China,8\r\n1039,王增武,李建军,王增武 and 李建军 are co-authors of the Chinese dyslipidemia management guidelines (2024 edition),8\r\n2883,李凌江,中南大学湘雅二医院,\"Li Lingjiang (李凌江) is a medical professional affiliated with the Second Xiangya Hospital of Central South University (中南大学湘雅二医院). He is a member of the hospital's neuropsychiatry expert team, specializing in the field of mental health and neurological disorders. His association with the renowned Second Xiangya Hospital highlights his involvement in a leading medical institution in China, where he contributes to clinical practice, research, or academic work in neuropsychiatry. The combined descriptions confirm his professional role and institutional connection without contradictions, emphasizing his expertise in this specialized medical domain.\",8\r\n589,张宇清,孙宁玲,Zhang Yuqing and Sun Ningling are co-authors of the guideline,6\r\n1056,陈源源,王增武,陈源源 and 王增武 co-authored an expert consensus on hypertension management,6\r\n1401,赵水平,中南大学湘雅二医院,\"赵水平 is affiliated with Xiangya Second Hospital, Central South University\",6\r\n2382,《中国高血压防治指南》修订委员会,中华心血管病杂志,The committee published guidelines in the Chinese Journal of Cardiology,6\r\n1408,中南大学湘雅二医院,彭道泉,彭道泉 is affiliated with Xiangya Hospital of Central South University,5\r\n2884,李凌江,精神疾病诊疗技术国家地方联合工程实验室,Li Lingjiang is associated with the National Local Joint Engineering Laboratory for Mental Disorders,5\r\n2885,李凌江,精神病学与精神卫生学湖南省重点实验室,Li Lingjiang is associated with the Hunan Key Laboratory of Psychiatry and Mental Health,5\r\n3117,中南大学湘雅二医院,胡治平,胡治平是中南大学湘雅二医院的专家,5\r\n801,中国医药科技出版社,郑筱萸,郑筱萸 authored guidelines published by 中国医药科技出版社,4\r\n1014,中国心血管健康与疾病报告编写组,“三高”共管规范化诊疗中国专家共识专家组,Both contribute to guidelines and reports on cardiovascular and metabolic disease management in China,3\r\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            },\n            {\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }\n        ]\n    }\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nLimit the total report length to 2000 words.\n\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_cf98341f7160205373b68647ee9b1d367cd08d4aea98644e550f20c0e5e9a452_v2"}